Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A proximity-dependent biotinylation map of a human cell. | Nature | 2021 | 34079125 | PubTator, text mining | PubMed |
| The Critical Role of TRIB2 in Cancer and Therapy Resistance. | Cancers (Basel) | 2021 | 34070799 | PubTator, text mining | PubMed |
| Altered Expression of Candidate Genes in Mayer-Rokitansky-Küster-Hauser Syndrome May Influence Vaginal Keratinocytes Biology: A Focus on Protein Kinase X. | Biology (Basel) | 2021 | 34063745 | PubTator, text mining | PubMed |
| Potential clinical biomarkers in rheumatoid arthritis with an omic approach. | Auto Immun Highlights | 2021 | 34059137 | PubTator, text mining | PubMed |
| An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics. | Acta Neuropathol Commun | 2021 | 34034831 | PubTator, text mining | PubMed |
| Prime editing - an update on the field. | Gene Ther | 2021 | 34031549 | PubTator, text mining | PubMed |
| FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation. | Signal Transduct Target Ther | 2021 | 34024909 | PubTator, text mining | PubMed |
| CNVxplorer: a web tool to assist clinical interpretation of CNVs in rare disease patients. | Nucleic Acids Res | 2021 | 34019647 | PubTator, text mining | PubMed |
| Neutralization of PD-L2 is Essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian Cancer. | Clin Cancer Res | 2021 | 34011561 | PubTator, text mining | PubMed |
| First case report of a NUP98-PMX1 rearrangement in de novo acute myeloid leukemia and literature review. | BMC Med Genomics | 2021 | 34001105 | PubTator, text mining | PubMed |
| Properties and gene expression profiling of acquired radioresistance in mouse breast cancer cells. | Ann Transl Med | 2021 | 33987326 | PubTator, text mining | PubMed |
| Relative independence of upper limb position sense and reaching in children with hemiparetic perinatal stroke. | J Neuroeng Rehabil | 2021 | 33980254 | PubTator, text mining | PubMed |
| A naphthalimide-polyamine conjugate preferentially accumulates in hepatic carcinoma metastases as a lysosome-targeted antimetastatic agent. | Eur J Med Chem | 2021 | 33965862 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma. | Front Immunol | 2021 | 33959132 | PubTator, text mining | PubMed |
| Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma. | Cancer Immunol Immunother | 2021 | 33956203 | PubTator, text mining | PubMed |
| Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival? | Cancers (Basel) | 2021 | 33925671 | PubTator, text mining | PubMed |
| NUP-98 Rearrangements Led to the Identification of Candidate Biomarkers for Primary Induction Failure in Pediatric Acute Myeloid Leukemia. | Int J Mol Sci | 2021 | 33925480 | PubTator, text mining | PubMed |
| VWF, Platelets and the Antiphospholipid Syndrome. | Int J Mol Sci | 2021 | 33919627 | PubTator, text mining | PubMed |
| Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review. | Cancers (Basel) | 2021 | 33918661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=35